Processing 00000000.tx.1: Genotype and phenotype in Alzheimer's disease CLIVE HOLMES, MRCPsych Thornhill Research Unit, University of Southampton, Moorgreen Hospital, Botley Road, West End, Southampton SO30 3JB, UK Declaration of interest None. 

Phrase: "Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "phenotype in Alzheimer's disease CLIVE HOLMES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "MRCPsych Thornhill Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439148:Unit [Quantitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]

Phrase: "University of Southampton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Moorgreen Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Botley Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "West End,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "Southampton SO30 3JB,"

Phrase: "UK Declaration of interest"

Phrase: "None."
Processing 00000000.tx.2: See editorial, pp. 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "editorial, pp."
Processing 00000000.tx.3: 9798, this issue. 

Phrase: "9798,"

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.4: ABSTRACT Background Patients with Alzheimer's disease show a wide variation in clinical phenotype. 

Phrase: "ABSTRACT Background Patients with Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a wide variation in clinical phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1846356:Clinical variation [Finding]
   753   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.5: Genetic research has been largely concerned with the role of mutations or common variants as risk factors for the disease. 

Phrase: "Genetic research"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
  1000   C0243064:Genetic Research [Research Activity]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "largely"

Phrase: "concerned with the role of mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0026882:Mutations [Genetic Function]
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
   719   C2699424:Concern [Idea or Concept]

Phrase: "or"

Phrase: "common variants as risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "for the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.6: Do genetic factors also influence clinical phenotype? 

Phrase: "Do"

Phrase: "genetic factors also"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "influence"

Phrase: "clinical phenotype?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.7: Aims To examine the evidence that genetic factors influence the clinical expression of the disease in addition to influencing risk. 

Phrase: "Aims"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]
  1000   C3540473:AIMS [Intellectual Product]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "influence"

Phrase: "the clinical expression of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in addition to influencing risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.8: Method A selective review was made of the key literature. 

Phrase: "Method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "A selective review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]

Phrase: "was"

Phrase: "made of the key literature."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023866:Literature [Intellectual Product]
   760   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   726   C1881534:Make [Functional Concept]
Processing 00000000.tx.9: Results Mutations in three genes, coding for amyloid precursor protein, presenilin-1 and presenilin-2, and a common variation (4) in another gene, APOE, have been shown to lead to an earlier development of the disease. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Mutations in three genes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "coding for amyloid precursor protein,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0009219:Coding [Occupational Activity]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "a common variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "in another gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to an earlier development of the disease."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   750   C0679245:early disease [Temporal Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711   C1279919:Early [Temporal Concept]
Processing 00000000.tx.10: More recently, genetic association and twin studies have suggested a role for genetic factors in the development of other aspects of clinical phenotype, notably the appearance of non-cognitive symptoms. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "twin studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0282476:twin studies [Research Activity]
  1000   C1096782:Twin Studies [Intellectual Product]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for genetic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of other aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1547011:Aspect [Quantitative Concept]
   966   C1879746:Aspect [Qualitative Concept]

Phrase: "of clinical phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "notably"

Phrase: "the appearance of non-cognitive symptoms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.11: Conclusions In Alzheimer's disease genetic variation influences a number of aspects of clinical phenotype. 

Phrase: "Conclusions In Alzheimer's disease genetic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707478:Conclusions [Idea or Concept]

Phrase: "influences"

Phrase: "a number of aspects of clinical phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.12: Early family and twin studies have indicated that a number of genes have an important part to play in the development of Alzheimer's disease. 

Phrase: "Early family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "twin studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0282476:twin studies [Research Activity]
  1000   C1096782:Twin Studies [Intellectual Product]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "an important part to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449719:Part [Spatial Concept]
   827   C1709471:Part [Quantitative Concept]

Phrase: "play in the development of Alzheimer's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0032214:Play [Daily or Recreational Activity]
   748   C0243107:development [Physiologic Function]
   748   C0600138:play [Finding]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.13: Variation in these genes, including both rare mutations and common polymorphisms, appears to confer increased risk for the development of the disease. 

Phrase: "Variation in these genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "both rare mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "common polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "increased risk for the development of the disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   721   C0277564:Acquired disease [Disease or Syndrome]
Processing 00000000.tx.14: However, apparent increased risk may be largely explained by the effects that genetic variation has on the clinical phenotype of Alzheimer's disease, particularly the age at which the disease presents. 

Phrase: "However,"

Phrase: "apparent increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   827   C0035647:Risk [Qualitative Concept]
   827   C0205217:Increased [Quantitative Concept]
   827   C0442805:Increased [Functional Concept]
   755 E C1517378:Gain [Quantitative Concept]
   734 E C0439661:Acquired [Temporal Concept]
   734 E C0442808:Increasing [Functional Concept]
   734 E C1301820:Obtain [Functional Concept]
   734 E C1706701:Acquire [Activity]
   734 E C3245488:acquired [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "largely"

Phrase: "explained by the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "that genetic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042333:Genetic Variation [Natural Phenomenon or Process]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "has on the clinical phenotype of Alzheimer's disease,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0205210:Clinical [Qualitative Concept]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C3539897:Has [Qualitative Concept]

Phrase: "particularly"

Phrase: "the age at which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "presents."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.15: More recently, it has been proposed that genetic variation may also explain some of the other features of clinical phenotype, including the development of non-cognitive symptoms. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that genetic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042333:Genetic Variation [Natural Phenomenon or Process]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "explain"

Phrase: "some of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "other features of clinical phenotype,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the development of non-cognitive symptoms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0679035:Cognitive Development [Mental Process]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   748   C0476236:Developmental symptoms [Sign or Symptom]
Processing 00000000.tx.16: GENES AS RISK FACTORS The clearest evidence for a genetic contribution to the aetiology of Alzheimer's disease is the existence of families in whom the disease is transmitted in a clear autosomal dominant pattern. 

Phrase: "GENES AS RISK FACTORS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "The clearest evidence for a genetic contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "to the aetiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the existence of families"

Phrase: "in whom"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "transmitted in a clear autosomal dominant pattern."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0443147:Autosomal dominant [Intellectual Product]
   748   C0242781:Transmitted [Pathologic Function]
   748   C0332289:transmitted [Functional Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1521797:Transmitted [Natural Phenomenon or Process]
   748   C1527180:Dominant [Functional Concept]
   748   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.17: Study of one of these large pedigrees revealed the transmission, from generation to generation, of a single point mutation in the gene for amyloid precursor protein (APP), found on chromosome 21 in family members developing early-onset Alzheimer's disease. 

Phrase: "Study of one of these large pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the transmission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040722:transmission [Idea or Concept]
  1000   C0242781:Transmission [Pathologic Function]
  1000   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "from generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "to generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of a single point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutation [Genetic Function]
   827   C1552961:Point [Quantitative Concept]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   827   C2347617:point [Quantitative Concept]

Phrase: "in the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "found on chromosome 21"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "in family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "developing"

Phrase: "early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.18: Further studies of these families led to the discovery of other point mutations in the same gene and later the presence of mutations in two other genes, encoding presenilin-1 (PS-1) and presenilin-2 (PS-2), found on chromosomes 14 and 1, respectively. 

Phrase: "Further studies of these families"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0199236:family studies [Diagnostic Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "led to the discovery of other point mutations"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   770   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   744   C0026882:Mutations [Genetic Function]
   744   C1552961:Point [Quantitative Concept]
   744   C1708698:LED [Manufactured Object]
   744   C1880355:Discovery [Activity]
   744   C2347617:point [Quantitative Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the same gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "later"

Phrase: "the presence of mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "presenilin-1 (PS-1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2 (PS-2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "found on chromosomes 14"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0008656:Chromosome 14 [Cell Component]
   770   C0008633:Chromosomes [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "respectively."
Processing 00000000.tx.19: To date, 12 Alzheimer's disease-related mutations have been discovered in the APP gene, 69 mutations in the PS-1 gene and 5 mutations in the PS-2 gene. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "12 Alzheimer's disease-related mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "discovered in the APP gene,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   714   C1880355:Discover [Activity]

Phrase: "69 mutations in the PS-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "5 mutations in the PS-2 gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.20: Significantly, research suggests that the different mutations in these three genes lead to a common result, an increase in -A4 peptide fragment of APP which forms the core of the neuritic plaques found in the brains of people with Alzheimer's disease. 

Phrase: "Significantly,"

Phrase: "research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the different mutations in these three genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to a common result,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205214:Common [Quantitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522138:Common [Functional Concept]
   760   C1522538:Lead [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2825142:Result [Finding]
   760   C3245511:common [Intellectual Product]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "an increase in -A4 peptide fragment of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030935:peptide fragment [Amino Acid, Peptide, or Protein]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the core of the neuritic plaques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C3274653:Core [Body Substance]

Phrase: "found in the brains of people"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0027361:People [Population Group]
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.21: While these findings are of immense importance in terms of elucidating the biological pathogenesis of Alzheimer's diease, it is important to recognise that these three causal genes may only account for 30-50% of all autosomal dominant early-onset cases, or around 10% of familial early-onset cases (Cruts et al, 1998). 

Phrase: "While"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are of immense importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551058:Are [Quantitative Concept]

Phrase: "in terms of elucidating"

Phrase: "the biological pathogenesis of Alzheimer's diease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "recognise"

Phrase: "that"

Phrase: "these three causal genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "may"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "account for 30-50%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "of all autosomal dominant early-onset cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "or around 10% of familial early-onset cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C1833334:Early-onset [Finding]
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0332162:Onset [Qualitative Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "(Cruts et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.22: Thus, given that in the majority of cases (> 95%) Alzheimer's disease occurs after the age of 60 years, it is clear that these genetic mutations make only a small contribution to the risk of developing the disease in general. 

Phrase: "Thus,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that in the majority of cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0680220:majority [Social Behavior]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "> 95%"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "occurs after the age of 60 years,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   774   C1510829:Age-Years [Temporal Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0439234:years [Temporal Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "these genetic mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026882:genetic mutations [Genetic Function]
           Mutations
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small contribution to the risk of developing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "the disease in general."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.23: The inheritance of late-onset Alzheimer's disease is more complex than that of the early-onset form. 

Phrase: "The inheritance of late-onset Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0242538:Inheritance [Quantitative Concept]
   748   C0728826:Inheritance [Functional Concept]

Phrase: "is"

Phrase: "more complex than that of the early-onset form."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.24: In cross-sectional studies the presence of a positive family history of late-onset Alzheimer's disease is a consistent risk factor for subjects with the late-onset form, but a clear autosomal dominant pattern of inheritance is rare. 

Phrase: "In cross-sectional studies"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0010362:Cross-Sectional Studies [Research Activity]
   865   C0552389:cross sections [Spatial Concept]
   827   C0205155:Sectional [Spatial Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C2828360:Cross [Conceptual Entity]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: "the presence of a positive family history of late-onset Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a consistent risk factor for subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035648:Risk factor [Quantitative Concept]
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C0035647:Risk [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "with the late-onset form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "a clear autosomal dominant pattern of inheritance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1136375:Pattern, Inheritance [Genetic Function]
   748   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "rare."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.25: Both twin and family studies suggest a polygenic multifactorial mode of inheritance and as a consequence the elucidation of genetic risk factors for late-onset Alzheimer's disease requires different methods from those used in the early-onset disease, with its simple Mendelian patterns of inheritance. 

Phrase: "Both twin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041427:Twin [Family Group]
  1000   C0205173:Twin [Functional Concept]

Phrase: "and"

Phrase: "family studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0199236:family studies [Diagnostic Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a polygenic multifactorial mode of inheritance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1708511:Mode of Inheritance [Functional Concept]
           Inheritance Mode
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "and as a consequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "the elucidation of genetic risk factors"

Phrase: "for late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "requires"

Phrase: "different methods from those"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "used in the early-onset disease,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C1833334:Early-onset [Finding]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1279919:Early [Temporal Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "with its simple Mendelian patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "of inheritance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242538:Inheritance [Quantitative Concept]
  1000   C0728826:Inheritance [Functional Concept]
Processing 00000000.tx.26: Association studies have so far dominated the genetics of late-onset Alzheimer's disease. 

Phrase: "Association studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "dominated"

Phrase: "the genetics of late-onset Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0019247:genetics disease [Disease or Syndrome]
   748   C0017398:Genetics [Biomedical Occupation or Discipline]
   748   C0017399:genetics [Biologic Function]
Processing 00000000.tx.27: Such studies look for variation in the frequency of an allele in samples of unrelated patients with late-onset Alzheimer's disease compared with unrelated control subjects. 

Phrase: "Such studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "look for variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205419:Variation [Qualitative Concept]
   790   C0233426:look [Organism Attribute]

Phrase: "in the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of an allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "of unrelated patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "compared with unrelated control subjects."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0243148:control [Qualitative Concept]
   760   C0445356:Unrelated [Finding]
   760   C1550141:Control [Substance]
   760   C1704623:Unrelated [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.28: These studies have resulted in a number of candidate genes being proposed as having importance as risk factors for late-onset Alzheimer's disease, and include associations with variation in genes encoding the very low-density lipoprotein (VLDL) receptor, PS-1 (an intronic mutation not associated with early-onset Alzheimer's disease), butyrylcholinesterase, angiotensin-1 converting enzyme, 1-antichymotrypsin, the human leucocyte antigen (HLA) complex, 2-macroglobulin, the low-density lipoprotein-like receptor, the serotonin transporter and interleukin-1. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "resulted in a number of candidate genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1332838:Candidate Genes [Gene or Genome]
   748   C0017337:Genes [Gene or Genome]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "being"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "as"

Phrase: "having"

Phrase: "importance as risk factors"

Phrase: "for late-onset Alzheimer's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "associations with variation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0004083:Associations [Mental Process]
   756 E C0439849:Association [Qualitative Concept]
   756 E C0596306:Association [Phenomenon or Process]
   756 E C0699792:association [Social Behavior]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the very low-density lipoprotein (VLDL) receptor,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "PS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "an intronic mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1881250:Intronic Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with early-onset Alzheimer's disease"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   901   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "butyrylcholinesterase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "angiotensin-1 converting enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "1-antichymotrypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443619:Antichymotrypsin [Amino Acid, Peptide, or Protein]

Phrase: "the human leucocyte antigen (HLA) complex,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C2327792:Human leukocyte antigen complex [Cell Component]
   923   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   812   C0003320:Antigen [Immunologic Factor]
   812   C0023516:Leucocyte [Cell]
   812   C0086418:Human [Human]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "2-macroglobulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the low-density lipoprotein-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "like receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "the serotonin transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0170657:serotonin transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420214:SEROTONIN TRANSPORTER [Gene or Genome]
   861   C0036751:Serotonin [Neuroreactive Substance or Biogenic Amine,Organic Chemical]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "interleukin-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.29: Typically, interest in these candidates has diminished as independent replication has not been forthcoming, and little evidence now remains for an important role for genetic variation in the VLDL receptor, PS-1 or 1-antichymotrypsin genes in the development of late-onset Alzheimer's disease. 

Phrase: "Typically,"

Phrase: "interest in these candidates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "has"

Phrase: "diminished as independent replication"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0085862:Independent [Idea or Concept]
   770   C0205216:Diminished [Quantitative Concept]
   770   C0598312:Replication [Genetic Function]
   770   C1299583:Independent [Finding]
   770   C1883725:replication [Qualitative Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "forthcoming,"

Phrase: "and"

Phrase: "little evidence now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "remains for an important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "for genetic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042333:Genetic Variation [Natural Phenomenon or Process]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "in the VLDL receptor,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "PS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "1-antichymotrypsin genes in the development of late-onset Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0017337:Genes [Gene or Genome]
   718   C0017340:Genes, Developmental [Gene or Genome]
   709   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.30: The other candidate genes still have their advocates and remain hotly disputed. 

Phrase: "The"

Phrase: "other candidate genes still"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "their advocates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510823:Advocates [Occupation or Discipline]

Phrase: "and"

Phrase: "remain"

Phrase: "hotly"

Phrase: "disputed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0680226:dispute [Social Behavior]
Processing 00000000.tx.31: More recently, the results of a number of linkage studies have become available. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "the results of a number of linkage studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0683954:results studies [Finding]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "have"

Phrase: "become"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.32: The methods used for linkage studies in complex non-Mendelian diseases such as late-onset Alzheimer's disease are less powerful than those used for the early-onset form. 

Phrase: "The methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "used for linkage"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0023745:linkage [Molecular Function]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "studies in complex non-Mendelian diseases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0012634:Diseases [Disease or Syndrome]
   753   C0439855:Complex [Qualitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C1518422:Non [Functional Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C2603343:Study [Research Activity]

Phrase: "such as late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "less powerful than those"

Phrase: "used for the early-onset form."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C1833334:Early-onset [Finding]
   753   C0332162:Onset [Qualitative Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1273517:used [Finding]
   753   C1279919:Early [Temporal Concept]
   753   C1522492:Form [Functional Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.33: However, such studies can reveal areas of interest in the genome that might later be explored by association studies. 

Phrase: "However,"

Phrase: "such studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "can"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "areas of interest"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205146:areas [Spatial Concept]
   756 E C0017446:Area [Geographic Area]

Phrase: "in the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "later"

Phrase: "be"

Phrase: "explored by association studies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.34: A complete genomic screen in a series of multiplex families affected with late-onset Alzheimer's disease has revealed five regions of interest on chromosomes 4, 6, 12, 19 and 20. 

Phrase: "A complete genomic screen in a series of multiplex families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220908:screen [Health Care Activity]
   739   C1305399:screen [Functional Concept]
   739   C1705053:Screen [Medical Device]

Phrase: "affected with late-onset Alzheimer's disease"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "has"

Phrase: "revealed five regions of interest"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   851   C0803113:Region of interest [Clinical Attribute]
   851   C0807727:Region of interest [Spatial Concept]
   851   C2827628:Region of Interest [Spatial Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "on chromosomes 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008667:Chromosome 4 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "6,"

Phrase: "12,"

Phrase: "19"

Phrase: "and"

Phrase: "20."
Processing 00000000.tx.35: Excluding the effects of the APOE4 locus, the maximum log likelihood ratio (lod) score in this study occurred in a region located on the short arm of chromosome 12 (Pericak-Vance et al, 1997). 

Phrase: "Excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the effects of the APOE4 locus,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "the maximum log likelihood ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "(lod) score in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0023956:Lod Score [Quantitative Concept]
   760   C0449820:Score [Quantitative Concept]
   760   C2247199:Lod [Molecular Function]

Phrase: "occurred in a region"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "located on the short arm of chromosome 12"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0457309:Short arm of chromosome [Cell Component]
   819   C1520467:Chromosome 12 Short Arm [Nucleotide Sequence]
   800   C0449721:Arm of chromosome [Nucleotide Sequence]
           Chromosome Arm
   770   C0008654:Chromosome 12 [Cell Component]
   770   C0426857:Short arm [Finding]
   744   C0008633:Chromosome [Cell Component]
   744   C0446516:Arm [Body Location or Region]
   744   C1269078:Arm [Body Part, Organ, or Organ Component]
   744   C1269612:Arm [Body Location or Region]
   744   C1282927:short [Qualitative Concept]
   744   C1806781:Short [Quantitative Concept]
   744   C2350002:Short [Quantitative Concept]

Phrase: "(Pericak-Vance et al,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.36: However, two subsequent studies following similar methods (Blacker et al, 1998; Wu et al, 1998) were unable to confirm linkage to this area. 

Phrase: "However,"

Phrase: "two subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "similar methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "(Blacker et al,"

Phrase: "1998"

Phrase: "; Wu et al,"

Phrase: "1998"

Phrase: ")"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "linkage to this area."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]
Processing 00000000.tx.37: A large sibpair study (Kehoe et al, 1999) has revealed many possible loci showing linkage to late-onset Alzheimer's disease. 

Phrase: "A large sibpair study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "(Kehoe et al,"

Phrase: "1999"

Phrase: ")"

Phrase: "has"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "many possible loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "linkage to late-onset Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0023745:linkage [Molecular Function]
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.38: These include loci on chromosomes 1, 5, 9, 10, 12, 14, 19 (close to APOE) and 21 (close to the APP gene). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "loci on chromosomes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1708726:Locus [Gene or Genome]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9,"

Phrase: "10,"

Phrase: "12,"

Phrase: "14,"

Phrase: "19"

Phrase: "(close to APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "21"

Phrase: "(close to the APP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0587267:Close [Functional Concept]

Phrase: ")."
Processing 00000000.tx.39: Currently, the main focus of attention is chromosome 10, with two independent studies showing evidence of a susceptibility locus in the same region (Ertekin-Taner et al, 2000; Myers et al, 2000). 

Phrase: "Currently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "the main focus of attention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0589098:attention focus [Mental Process]
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]

Phrase: "is"

Phrase: "chromosome 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "with two independent studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0681367:independent study [Educational Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of a susceptibility locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the same region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(Ertekin-Taner et al,"

Phrase: "2000"

Phrase: "; Myers et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.40: However, it is clear that a large number of loci are implicated and that there is some disagreement between studies in the predicted areas of interest. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "a large number of loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "implicated"

Phrase: "and"

Phrase: "that there"

Phrase: "is"

Phrase: "some disagreement between studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680238:Disagreement [Social Behavior]

Phrase: "in the predicted areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "of interest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]
Processing 00000000.tx.41: These findings demonstrate some of the limitations of this approach, but also serve to emphasise the polygenic nature of late-onset Alzheimer's disease. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "some of the limitations of this approach,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205392:Some [Quantitative Concept]
   748   C0449295:limitations [Functional Concept]
   748   C0449445:Approach [Spatial Concept]
   748   C3540770:Some [Intellectual Product]

Phrase: "but"

Phrase: "also"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emphasise"

Phrase: "the polygenic nature of late-onset Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0449786:Nature of disease [Qualitative Concept]
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]
Processing 00000000.tx.42: Further exploration of these areas by association studies  the positional candidate approach  is likely to dominate the genetics of Alzheimer's disease in the future. 

Phrase: "Further exploration of these areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "by association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "the positional candidate approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "dominate"

Phrase: "the genetics of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0019247:genetics disease [Disease or Syndrome]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]

Phrase: "in the future."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]
Processing 00000000.tx.43: Of the genetic risk factors that have been advocated as having a role in the development of late-onset Alzheimer's disease, the least controversial remains the increased risk associated with possession of one or more copies of the APOE4 allele, coding for the apolipoprotein E (ApoE) variant 4. 

Phrase: "Of the genetic risk factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0814299:genetic risk factors [Qualitative Concept]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   734   C1517512:Genetic Risk [Quantitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "advocated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510823:Advocate [Occupation or Discipline]

Phrase: "as"

Phrase: "having"

Phrase: "a role in the development of late-onset Alzheimer's disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "the least controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]

Phrase: "remains"

Phrase: "the increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "associated with possession of one"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205447:One [Quantitative Concept]
   760   C0871103:possession [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "copies of the APOE4 allele,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C3642141:APOE*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C1948062:Copies [Manufactured Object]
   760   C2984964:APOE4 [Laboratory Procedure]

Phrase: "coding for the apolipoprotein E (ApoE) variant 4."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0009219:Coding [Occupational Activity]
   748   C0205419:Variant [Qualitative Concept]
   714 E C0805701:Code [Intellectual Product]
Processing 00000000.tx.44: Significantly, the importance of APOE4 was determined using a positional candidate gene approach. 

Phrase: "Significantly,"

Phrase: "the importance of APOE4"

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a positional candidate gene approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.45: Since this finding, other studies (Artiga et al, 1998; Bullido et al, 1998; Lambert et al, 1998) have also suggested an association between a number of polymorphisms within the transcriptional regulatory region of the APOE gene and late-onset Alzheimer's disease that is independent of ApoE 4 status. 

Phrase: "Since"

Phrase: "this finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(Artiga et al,"

Phrase: "1998"

Phrase: "; Bullido et al,"

Phrase: "1998"

Phrase: "; Lambert et al,"

Phrase: "1998"

Phrase: ")"

Phrase: "have"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an association between a number of polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "within the transcriptional regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "is independent of ApoE 4 status."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332291:Independent of [Functional Concept]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0449438:Status [Qualitative Concept]
   748   C1299583:Independent [Finding]
Processing 00000000.tx.46: Based on these data, it was suggested that there are two independent mechanisms by which risk of late-onset Alzheimer's disease can be modified by the APOE gene: first, by variations in the coding regions, which alter the functional properties of APOE; 

Phrase: "Based on these data,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "it"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "two independent mechanisms by which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "risk of late-onset Alzheimer's disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C1281905:disease risk [Finding]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "modified by the APOE gene"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0205349:Modified By [Qualitative Concept]
   806   C1412481:APOE gene [Gene or Genome]
           APOE
   797   C1517476:Gene-Modified [Qualitative Concept]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0392747:Modified [Functional Concept]
   760   C0523511:APOE [Laboratory Procedure]

Phrase: ":"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "by variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variations [Qualitative Concept]

Phrase: "in the coding regions,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "which"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the functional properties of APOE"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: ";"
Processing 00000000.tx.47: and second, by the presence of promoter variants which result in quantitative differences in APOE expression (Artiga et al, 1998). 

Phrase: "and"

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "by the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of promoter variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "which"

Phrase: "result in quantitative differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C1709795:Quantitative Result [Finding]
   770   C0392762:Quantitative [Quantitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Artiga et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.48: However, this hypothesis is controversial, and more recent studies (Helisalmi et al, 1999; Zurutuza et al, 2000) have failed to support the independence of APOE promoter variants in the development of Alzheimer's disease. 

Phrase: "However,"

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "controversial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "and"

Phrase: "more recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "(Helisalmi et al,"

Phrase: "1999"

Phrase: "; Zurutuza et al,"

Phrase: "2000"

Phrase: ")"

Phrase: "have"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the independence of APOE promoter variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332291:Independent of [Functional Concept]
   753   C0085862:Independence [Idea or Concept]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.49: GENETIC INFLUENCES ON CLINICAL PHENOTYPE Age of onset Families carrying mutations in the APP gene have ages of onset largely within the range 40-65 years. 

Phrase: "GENETIC INFLUENCES ON CLINICAL PHENOTYPE Age of onset Families"

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "mutations in the APP gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "ages of onset largely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "within the range 40-65 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.50: To date, no APP mutation carrier has been reported to be unaffected beyond the age of 67 years. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "no APP mutation carrier"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C2985478:Mutation Carrier [Human]
   804   C0007294:Carrier [Finding]
   804   C0560175:Carrier [Finding]
   804   C1706209:Carrier [Medical Device]
   804   C3273162:Carrier [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unaffected beyond the age of 67 years."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.51: Families carrying mutations in the PS-1 gene have the earliest ages of onset, which fall largely within the range 35-55 years, although one such family member has recently been recorded with onset at 24 years (Wisniewski et al, 1998). 

Phrase: "Families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "mutations in the PS-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "the earliest ages of onset,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   918   C1835401:Early age of onset [Finding]
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "which"

Phrase: "fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "largely within the range 35-55 years,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0439234:years [Temporal Concept]
   748   C0450382:55 [Intellectual Product]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]
   714 E C0439508:/year [Temporal Concept]

Phrase: "although"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such family member"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086282:Family member [Family Group]
  1000   C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:member [Population Group]
   861   C1704727:Family [Conceptual Entity]
   861   C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "recorded with onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332162:Onset [Qualitative Concept]
   756   C0034869:Record [Intellectual Product]

Phrase: "at 24 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Wisniewski et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.52: These mutations are largely associated with early-onset familial Alzheimer's disease, but at least two of these mutations (Ala79Val and His163Tyr) have been observed with late-onset Alzheimer's disease and may be non-penetrant (Cruts et al, 1998). 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "largely"

Phrase: "associated with early-onset familial Alzheimer's disease,"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   870   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1833334:Early-onset [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   738 E C0344339:disease family [Finding]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but at least two of these mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0026882:Mutations [Genetic Function]
   748   C0205448:Two [Quantitative Concept]
   748   C0233535:but [Mental or Behavioral Dysfunction]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Ala79Val"

Phrase: "and"

Phrase: "His163Tyr"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "observed with late-onset Alzheimer's disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "non-penetrant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "(Cruts et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.53: Families carrying mutations in the PS-2 gene have ages of onset largely within the range 40-70 years and thus show some overlap with late-onset Alzheimer's disease. 

Phrase: "Families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "mutations in the PS-2 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "ages of onset largely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "within the range 40-70 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "some overlap with late-onset Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185027:overlap [Therapeutic or Preventive Procedure]
   748   C1948020:Overlap [Conceptual Entity]
   704   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.54: Penetrance is high but may not be 100%, with at least two reported cases of non-penetrance over the age of 80 years (Bird et al, 1996). 

Phrase: "Penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524899:Penetrance [Quantitative Concept]

Phrase: "is"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "but"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "100%,"

Phrase: "with"

Phrase: "at least two reported cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "of non-penetrance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0524899:Penetrance [Quantitative Concept]
   861   C1518422:Non [Functional Concept]

Phrase: "over the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 80 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Bird et al,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.55: The familial influence on age of onset in late-onset Alzheimer's disease may be substantial. 

Phrase: "The familial influence on age of onset"

Phrase: "in late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "substantial."
Processing 00000000.tx.56: Thus, one study of affected sib pairs suggests that shared familial effects may account for 40% of the variance (Tunstall et al, 2000). 

Phrase: "Thus,"

Phrase: "one study of affected sib pairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that shared familial effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "account for 40% of the variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0439509:/40 [Temporal Concept]
   753   C1551359:account [Idea or Concept]
   753   C1711260:Variance [Qualitative Concept]
   753   C2348152:Variance [Quantitative Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "(Tunstall et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.57: Indeed, studies have shown that in the late-onset disease the age of onset is approximately 6 years earlier in individuals who carry two copies of the APOE4 allele compared with non-carriers. 

Phrase: "Indeed,"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in the late-onset disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0814122:late disease onset [Finding]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "the age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "approximately 6 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "earlier in individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1279919:Early [Temporal Concept]

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "two copies of the APOE4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948062:Copies [Manufactured Object]

Phrase: "compared with non-carriers."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007294:carriers [Finding]
   770   C1518422:Non [Functional Concept]
   770   C1707455:Compared [Activity]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.58: This has led to the suggestion that the APOE4 allele is a risk factor for Alzheimer's disease mainly because in old age Alzheimer's disease and death are competing risks. 

Phrase: "This"

Phrase: "has"

Phrase: "led to the suggestion"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0038659:Suggestion [Idea or Concept]
   770   C1705535:suggestion [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "the APOE4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "a risk factor for Alzheimer's disease mainly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "because in old age Alzheimer's disease"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0231337:Old age [Finding]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C1999167:Old age [Population Group]
   753   C0001779:Age [Organism Attribute]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0580836:Old [Temporal Concept]
   734 E C0392079:Senile [Finding]

Phrase: "and"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "are"

Phrase: "competing risks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risks [Qualitative Concept]
Processing 00000000.tx.59: Any factor leading to an earlier age of onset of Alzheimer's disease in the elderly (and hence the development of the disease prior to death) will be associated with Alzheimer's disease. 

Phrase: "Any factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "leading to an earlier age of onset of Alzheimer's disease"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   798   C1835401:Early age of onset [Finding]
   784   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   782   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   764   C0814120:early disease onset [Disease or Syndrome]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0277793:disease onset [Temporal Concept]
   741   C0679245:early disease [Temporal Concept]
   741   C1833334:Early-onset [Finding]
   739   C0001779:Age [Organism Attribute]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0332152:Leading [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C1522538:Leading [Functional Concept]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706   C1279919:Early [Temporal Concept]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]

Phrase: "("

Phrase: "and"

Phrase: "hence"

Phrase: "the development of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "prior to death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: ")"

Phrase: "will"

Phrase: "be"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.60: Evidence confirming this hypothesis has come from a large study of approximately 5000 individuals (Meyer et al, 1998). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "come from a large study of approximately 5000 individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0332232:Approximately [Qualitative Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C0557651:Study [Manufactured Object]
   742   C2603343:Study [Research Activity]
   708   C0027361:Individual [Population Group]
   708   C0237401:Individual [Human]

Phrase: "(Meyer et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.61: This study showed a clear decline in relative risk of developing late-onset Alzheimer's disease in all subjects with increasing age but with a clear plateau beyond which no further new cases of the disease were reported. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a clear decline in relative risk of developing late-onset Alzheimer's disease"

Phrase: "in all"

Phrase: "subjects with increasing age"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C2348575:Subject Age [Organism Attribute]
   770   C0001779:Age [Organism Attribute]
   770   C0442808:Increasing [Functional Concept]
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "but with a clear plateau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C2963144:Clear [Qualitative Concept]
   760   C2964353:Plateau [Quantitative Concept]

Phrase: "beyond which"

Phrase: "no further new cases of the disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.62: The age at which this plateau was reached was earlier in carriers of the APOE4 allele. 

Phrase: "The age at which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "this plateau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "was"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "was"

Phrase: "earlier in carriers of the APOE4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1279919:Early [Temporal Concept]
Processing 00000000.tx.63: Thus, it appears clear that the APOE4 allele has its predominant effect by determining when, but not if, an individual develops late-onset Alzheimer's disease (Meyer et al, 1998). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the APOE4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "its predominant effect by determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "when"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "if"

Phrase: ","

Phrase: "an individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "develops"

Phrase: "late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(Meyer et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.64: Non-cognitive features If genetic risk factors for Alzheimer's disease are associated with non-cognitive symptoms, then one might anticipate that subjects with a family history of the disease have an increased frequency of these symptoms. 

Phrase: "Non-cognitive features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "If"

Phrase: "genetic risk factors for Alzheimer's disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0814299:genetic risk factors [Qualitative Concept]
   814   C0850664:disease factors risk [Finding]
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   783   C0679238:disease factors [Functional Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "associated with non-cognitive symptoms,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0525041:Cognitive Symptoms [Sign or Symptom]
   797   C0521989:associated symptoms [Sign or Symptom]
   760   C0683368:symptoms [Functional Concept]
   760   C1457887:Symptoms [Sign or Symptom]
   760   C1516691:Cognitive [Functional Concept]
   760   C1518422:Non [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "then one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "anticipate"

Phrase: "that subjects with a family history of the disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "have"

Phrase: "an increased frequency of these symptoms."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   809   C0436350:Frequency of symptom [Temporal Concept]
           Symptom frequency
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.65: Likewise, one would expect an association between known genetic risk factors for Alzheimer's disease, including the genes for APP, PS-1, PS-2 and the ApoE 4 allele, and these symptoms in Alzheimer's disease. 

Phrase: "Likewise,"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "an association between known genetic risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "for Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the genes for APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Genes [Gene or Genome]

Phrase: "PS-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "the ApoE 4 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "these symptoms in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0683368:symptoms [Functional Concept]
   760   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.66: In fact, there appears to be little consistent evidence of an association between either a positive family history of Alzheimer's disease or variation in known candidate genes and an increase in the frequency of non-cognitive symptoms occurring for the first time within the disease. 

Phrase: "In fact,"

Phrase: "there"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "little consistent evidence of an association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between either"

Phrase: "a positive family history of Alzheimer's disease"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   840   C0850707:family history of disease [Finding]
           disease family history
   778   C0241889:Family history [Finding]
   778   C1705495:Family History [Idea or Concept]
   777   C0683519:History of diseases [Finding]
           disease history
   774   C0344339:disease family [Finding]
   769   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   748   C0015576:Family [Family Group]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1704727:Family [Conceptual Entity]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]
   738 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "or"

Phrase: "variation in known candidate genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "an increase in the frequency of non-cognitive symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "occurring for the first time"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "within the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.67: It thus seems unlikely that major genetic risk factors for the development of late-onset Alzheimer's disease have a substantial role to play in the development of non-cognitive symptoms within the late-onset disease. 

Phrase: "It thus"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that major genetic risk factors for the development of late-onset Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   766   C0814299:genetic risk factors [Qualitative Concept]
   766   C0850664:risk factor (of) disease [Finding]
           disease factors risk
   750   C0035648:risk factors [Quantitative Concept]
   750   C1553898:risk factors [Idea or Concept]
   749   C0679238:disease factors [Functional Concept]
   702   C1521761:Factor [Functional Concept]
   702   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "a substantial role to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "play in the development of non-cognitive symptoms"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0525041:Cognitive Symptoms [Sign or Symptom]
   767   C0679035:Cognitive Development [Mental Process]
   744   C0032214:Play [Daily or Recreational Activity]
   744   C0243107:development [Physiologic Function]
   744   C0600138:play [Finding]
   744   C0678723:Development [Organism Function]
   744   C0683368:symptoms [Functional Concept]
   744   C1457887:Symptoms [Sign or Symptom]
   744   C1516691:Cognitive [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1527148:Development [Functional Concept]
   731   C0476236:Developmental symptoms [Sign or Symptom]

Phrase: "within the late-onset disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.68: However, this does not mean that these symptoms have no genetic basis, since genes may influence the phenotypic expression of the disease without being involved directly in its aetiology. 

Phrase: "However,"

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "these symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "have"

Phrase: "no genetic basis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "since"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "may"

Phrase: "influence"

Phrase: "the phenotypic expression of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031437:Phenotypic expression [Organism Attribute]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "without"

Phrase: "being"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "directly in its aetiology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015127:aetiology [Functional Concept]
   770   C1314792:Aetiology [Functional Concept]
   770   C1524003:Etiology [Conceptual Entity]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.69: Indeed, early studies have shown evidence of an association between a positive family history of depressive illness and an increase in the frequency of depressive symptoms occurring for the first time within Alzheimer's disease (Pearlson et al, 1990). 

Phrase: "Indeed,"

Phrase: "early studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of an association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between a positive family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]

Phrase: "of depressive illness"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011581:Depressive illness [Mental or Behavioral Dysfunction]
   861   C0221423:Illness [Finding]
   789 E C0231218:Ill [Sign or Symptom]
   789 E C0332271:worse [Qualitative Concept]
   789 E C1279889:Worse [Finding]
   789 E C1457868:Worse [Qualitative Concept]
   789 E C1522166:Worst [Qualitative Concept]

Phrase: "and"

Phrase: "an increase in the frequency of depressive symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "occurring for the first time"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "within Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Pearlson et al,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.70: These early findings are supported by a sib-pair study (Tunstall et al, 2000) showing that familial factors have a role in the development of depressive illness in late-onset Alzheimer's disease. 

Phrase: "These early findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "supported by a sib-pair study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0037047:Sib [Family Group]
   753   C0557651:Study [Manufactured Object]
   753   C1521721:Supported [Conceptual Entity]
   753   C1709450:Pair [Qualitative Concept]
   753   C2603343:Study [Research Activity]
   719 E C0183683:Support [Medical Device]

Phrase: "(Tunstall et al,"

Phrase: "2000"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that familial factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "a role in the development of depressive illness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.71: In addition, this small study also suggests a role for familial factors in a wide variety of non-cognitive symptoms, including agitation, aggression and psychosis. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "this small study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for familial factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0680074:family role [Social Behavior]
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in a wide variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of non-cognitive symptoms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0525041:Cognitive Symptoms [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "agitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "aggression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001807:Aggression [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "psychosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]
Processing 00000000.tx.72: A more direct approach has also been adopted whereby common genetic polymorphisms previously showing associations with other neuropsychiatric conditions have been found to be associated with non-cognitive symptoms in late-onset Alzheimer's disease. 

Phrase: "A more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "adopted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]

Phrase: "whereby common genetic polymorphisms previously"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "associations with other neuropsychiatric conditions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with non-cognitive symptoms"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0525041:Cognitive Symptoms [Sign or Symptom]
   797   C0521989:associated symptoms [Sign or Symptom]
   760   C0683368:symptoms [Functional Concept]
   760   C1457887:Symptoms [Sign or Symptom]
   760   C1516691:Cognitive [Functional Concept]
   760   C1518422:Non [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.73: For example, one study (Holmes et al, 1998) of people with late-onset Alzheimer's disease found an association between common polymorphic variations in the 5-HT2A and 5-HT2C serotonin receptor genes (102-T/C and Cys23Ser polymorphisms, respectively), previously implicated in schizophrenia and bipolar affective disorder, with psychotic symptoms in Alzheimer's disease. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(Holmes et al,"

Phrase: "1998"

Phrase: ")"

Phrase: "of people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027361:People [Population Group]

Phrase: "with late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an association between common polymorphic variations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "in the 5-HT2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415809:5-HT2A [Gene or Genome]
  1000   C1708300:5-HT2A [Gene or Genome]
   861   C1424232:HT2A [Gene or Genome]

Phrase: "and"

Phrase: "5-HT2C serotonin receptor genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   823   C1335671:Receptor Gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   771   C0528200:Receptor, Serotonin, 5-HT2C [Amino Acid, Peptide, or Protein,Receptor]
           5-HT2C Receptor

Phrase: "(102-T/C"

Phrase: "and"

Phrase: "Cys23Ser polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "previously"

Phrase: "implicated in schizophrenia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "bipolar affective disorder,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0005586:Bipolar affective disorder [Mental or Behavioral Dysfunction]
           Bipolar Disorder
   901   C0525045:Affective disorder [Mental or Behavioral Dysfunction]
   827   C0012634:Disorder [Disease or Syndrome]
   827   C0443156:Bipolar [Spatial Concept]

Phrase: "with psychotic symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871189:psychotic symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.74: Associations were found between the presence of the C102 allele and the presence of visual and auditory hallucinations and between the presence of the Ser23 allele and visual hallucinations. 

Phrase: "Associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "found between the presence of the C102 allele"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0002085:Allele [Gene or Genome]
   744   C0150312:Found [Quantitative Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   711 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "the presence of visual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "auditory hallucinations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233762:Hallucinations, Auditory [Sign or Symptom]
   861   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
   861   C0439825:Auditory [Functional Concept]

Phrase: "and between the presence of the Ser23 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002085:Allele [Gene or Genome]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "visual hallucinations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233763:Hallucinations, Visual [Sign or Symptom]
   861   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
   861   C0234621:Visual [Functional Concept]
Processing 00000000.tx.75: Another study (Sweet et al, 1998) has found evidence to suggest an association of psychosis and aggression in patients with Alzheimer's disease who carry common polymorphisms in the dopamine receptor genes DRD1 and DRD3. 

Phrase: "Another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(Sweet et al,"

Phrase: "1998"

Phrase: ")"

Phrase: "has"

Phrase: "found evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an association of psychosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "aggression in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001807:Aggression [Mental or Behavioral Dysfunction]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "common polymorphisms in the dopamine receptor genes DRD1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "DRD3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414148:DRD3 [Gene or Genome]
Processing 00000000.tx.76: These studies need to be replicated but they suggest that common receptor polymorphisms may have a role in the genesis of psychotic or other non-cognitive symptoms that are not implicated as genetic risk factors for late-onset Alzheimer's disease. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "but"

Phrase: "they"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that common receptor polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a role in the genesis of psychotic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "other non-cognitive symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0525041:Cognitive Symptoms [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "that"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "implicated as genetic risk factors"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   862   C0814299:genetic risk factors [Qualitative Concept]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1517512:Genetic Risk [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0035647:Risk [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "for late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.77: Cognitive decline No study to date has looked at rates of decline in carriers of APP, PS-1 and PS-2 mutations, but patients with late-onset Alzheimer's disease who have a positive family history of Alzheimer's disease show no evidence of increased rates of decline. 

Phrase: "Cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "decline"

Phrase: "No study to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C2348558:Study Date [Temporal Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "looked at rates of decline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0233426:look [Organism Attribute]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "PS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS-2 mutations,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "but"

Phrase: "patients with late-onset Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030705:Patients [Patient or Disabled Group]
   734   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset

Phrase: "who"

Phrase: "have"

Phrase: "a positive family history of Alzheimer's disease"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   840   C0850707:family history of disease [Finding]
           disease family history
   778   C0241889:Family history [Finding]
   778   C1705495:Family History [Idea or Concept]
   777   C0683519:History of diseases [Finding]
           disease history
   774   C0344339:disease family [Finding]
   769   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   748   C0015576:Family [Family Group]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1704727:Family [Conceptual Entity]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]
   738 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no evidence of increased rates of decline."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.78: The majority of studies have also failed to show any relationships between possession of the APOE4 allele and increased rates of decline. 

Phrase: "The majority of studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "have"

Phrase: "also"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any relationships between possession of the APOE4 allele"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0439849:Relationships [Qualitative Concept]
   711 E C1705630:Relationship [Idea or Concept]
   711 E C1706279:Relationship [Idea or Concept]
   711 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "increased rates of decline."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.79: This lack of association is interesting since it implies that genetic factors may determine only when the disease starts, not the rate of degeneration. 

Phrase: "This lack of association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "since"

Phrase: "it"

Phrase: "implies"

Phrase: "that genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "may"

Phrase: "determine"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "the disease starts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439659:Start [Temporal Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the rate of degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.80: Clearly, caution is required when interpreting a negative finding and it may be that associations will always be difficult to establish because of the large number of confounding factors which may influence cognitive deterioration as well as difficulties with the use of psychometric scales over short periods. 

Phrase: "Clearly,"

Phrase: "caution"

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "when"

Phrase: "interpreting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpreting [Functional Concept]

Phrase: "a negative finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1513916:Negative Finding [Finding]
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "and"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "that associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "will"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "be"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "establish because of the large number of confounding factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0237753:*Number [Quantitative Concept]
   742   C0443211:establish [Qualitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0549177:Large [Quantitative Concept]
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "may"

Phrase: "influence"

Phrase: "cognitive deterioration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0854193:Cognitive deterioration [Mental or Behavioral Dysfunction]
   861   C0868945:Deterioration [Phenomenon or Process]

Phrase: "as well as"

Phrase: "difficulties with the use of psychometric scales"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1299586:difficulties [Finding]

Phrase: "over short periods."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425946:Short periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.81: Indeed, a study by Craft et al (1998) has suggested that there is an increased rate of cognitive decline in APOE4 carriers, which may be detectable by using a long follow-up period. 

Phrase: "Indeed,"

Phrase: "a study by Craft et al (1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "has"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "an increased rate of cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in APOE4 carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "detectable by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a long follow-up period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.82: Duration The mean duration of illness in families with PS-1 mutations is significantly shorter (range 5.8-6.8 years) than in families with both PS-2 (range 4.4-10.8 years) and APP mutations (range 9.0-16 years), reflecting the severity of PS-1-associated Alzheimer's disease. 

Phrase: "Duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "The mean duration of illness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C3176590:Duration of illness [Clinical Attribute]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with PS-1 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "is"

Phrase: "significantly shorter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1282927:short [Qualitative Concept]
   827   C1806781:Short [Quantitative Concept]
   827   C2350002:Short [Quantitative Concept]

Phrase: "(range 5.8-6.8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "than"

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with both PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(range 4.4-10.8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(range 9.0-16 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the severity of PS-1-associated Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0521117:disease severity [Qualitative Concept]
   744   C0439793:Severity [Qualitative Concept]
   744   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.83: Studies of late-onset Alzheimer's disease suggest that the duration of illness tends to be longer in people who have a positive family history or in carriers of the APOE4 allele. 

Phrase: "Studies of late-onset Alzheimer's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the duration of illness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C3176590:Duration of illness [Clinical Attribute]
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "longer in people"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0205166:Long [Qualitative Concept]
   756   C1706317:Long [Qualitative Concept]
   706 E C1444754:Length [Quantitative Concept]
   706 E C1706316:LENGTH [Research Activity]

Phrase: "who"

Phrase: "have"

Phrase: "a positive family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]

Phrase: "or in carriers of the APOE4 allele."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C3642141:APOE*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
   748   C0007294:carriers [Finding]
   748   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   748   C2984964:APOE4 [Laboratory Procedure]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.84: However, it has since been shown that this relationship no longer holds true once the confounding effects of age of onset have been taken into account. 

Phrase: "However,"

Phrase: "it"

Phrase: "has"

Phrase: "since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "holds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553387:Hold [Idea or Concept]
  1000   C1948035:Hold [Activity]

Phrase: "true once"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205238:True [Qualitative Concept]

Phrase: "the confounding effects of age of onset"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "taken into account."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.85: Thus, in late-onset Alzheimer's disease, increased survival is more directly related to an earlier age of onset, which is influenced by a number of factors that are not exclusively genetic. 

Phrase: "Thus,"

Phrase: "in late-onset Alzheimer's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "increased survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "is"

Phrase: "more directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "related to an earlier age of onset,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   845   C1835401:Early age of onset [Finding]
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   757   C1833334:Early-onset [Finding]
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   714 E C0163712:Relate [Organic Chemical]
   714   C1279919:Early [Temporal Concept]

Phrase: "which"

Phrase: "is"

Phrase: "influenced by a number of factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0814287:factors influence [Clinical Attribute]
   767   C0960756:factor A [Organic Chemical]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "not exclusively genetic."
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]
Processing 00000000.tx.86: Clinical Implications and Limitations CLINICAL IMPLICATIONS A number of genes have been implicated as risk factors for the development of Alzheimer's disease. 

Phrase: "Clinical Implications"

Phrase: "and"

Phrase: "Limitations CLINICAL IMPLICATIONS"

Phrase: "A number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated as risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0035648:risk factors [Quantitative Concept]
   833   C1553898:risk factors [Idea or Concept]
   770   C0035647:Risk [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.87: Variation in some of these genes appears to have a major effect in determining when  not if  the disease will develop. 

Phrase: "Variation in some of these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a major effect in determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "when"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "if"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "will"

Phrase: "develop."
Processing 00000000.tx.88: Other aspects of clinical phenotype, notably non-cognitive symptoms, are also influenced by genetic variation. 

Phrase: "Other aspects of clinical phenotype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0683325:clinical aspects [Clinical Attribute]
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "notably non-cognitive symptoms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0525041:Cognitive Symptoms [Sign or Symptom]
   812   C0683368:symptoms [Functional Concept]
   812   C1457887:Symptoms [Sign or Symptom]

Phrase: "are"

Phrase: "also"

Phrase: "influenced by genetic variation."
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   833   C0042333:Genetic Variation [Natural Phenomenon or Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205419:Variation [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.89: LIMITATIONS A number of other risk genes have yet to be identified. 

Phrase: "LIMITATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "A number of other risk genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.90: The influence of these unknown genes on clinical phenotype is as yet undetermined. 

Phrase: "The influence of these unknown genes"

Phrase: "on clinical phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is as yet undetermined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205258:Undetermined [Idea or Concept]
   770   C3536725:Undetermined [Qualitative Concept]
Processing 00000000.tx.91: The influence of genetic variation on non-cognitive symptoms is relatively unexplored. 

Phrase: "The influence of genetic variation"

Phrase: "on non-cognitive symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0525041:Cognitive Symptoms [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "is"

Phrase: "relatively unexplored."
Processing 00000000.tx.92: REFERENCES Artiga, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Artiga,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.93: J., Bullido, M. 

Phrase: "J.,"

Phrase: "Bullido,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.94: J., Frank, A., et al (1998) Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. 

Phrase: "J.,"

Phrase: "Frank,"

Phrase: "A.,"

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Risk for Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "correlates with transcriptional activity of the APOE gene."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1412481:APOE gene [Gene or Genome]
           APOE
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.95: Human Molecular Genetics, 7, 1887-1892.[Abstract/Free FullText] Bird, T. 

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "7,"

Phrase: "1887-1892."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.96: D., Levy-Lahad, E., Poorkaj, P., et al (1996) Wide range in age of onset for chromosome I-related familial Alzheimer's disease. 

Phrase: "D."

Phrase: ","

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Wide range in age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "for chromosome I-related familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   861   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   859   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   839   C0277558:Familial disease [Disease or Syndrome]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   803 E C0344339:family disease [Finding]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0015576:familial [Family Group]
   799   C0241888:Familial [Functional Concept]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]
   727 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.97: Annals of Neurology, 40, 932-936.[Medline] Blacker, D., Wilcox, M. 

Phrase: "Annals of Neurology,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "932-936."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.98: A., Laird, N. 

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.99: M., et al (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. 

Phrase: "M."

Phrase: ","

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "genetically"

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.100: Nature Genetics, 19, 357-360.[CrossRef][Medline] Bullido, M. 

Phrase: "Nature Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "19,"

Phrase: "357-360."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bullido,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.101: J., Artiga, M. 

Phrase: "J.,"

Phrase: "Artiga,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.102: J., Recuero, M., et al (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. 

Phrase: "J.,"

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1998"

Phrase: ")"

Phrase: "A polymorphism in the regulatory region of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.103: Nature Genetics, 18, 69-71.[Medline] Craft, S., Teri, L., Edland, S. 

Phrase: "Nature Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "18,"

Phrase: "69-71."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450388:69 [Intellectual Product]
   861   C0450389:71 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Craft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870369:craft [Manufactured Object]

Phrase: "S."

Phrase: ","

Phrase: "Teri,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Edland,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.104: D., et al (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. 

Phrase: "D."

Phrase: ","

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Accelerated decline in apolipoprotein E-epsilon4 homozygotes"

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.105: Neurology, 51, 149-153.[Abstract] Cruts, M., van Duijn, C. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "149-153."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.106: M., Backhovens, H., et al (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. 

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Estimation of the genetic contribution of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0680844:estimation [Mental Process]
   744   C0681916:Estimation [Quantitative Concept]
   744   C0750572:Estimation [Quantitative Concept]

Phrase: "and -"

Phrase: "2 mutations in a population-based study of presenile Alzheimer disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.107: Human Molecular Genetics, 7, 43-51.[Abstract/Free FullText] Ertekin-Taner, N., Graff-Radford, N., Younkin, L., et al (2000) Linkage of plasma A  42 to a quantitative locus on chromosome 10 in late onset Alzheimer's disease pedigrees. 

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "7,"

Phrase: "43-51."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Graff-Radford,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Linkage of plasma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023745:linkage [Molecular Function]

Phrase: "A  42 to a quantitative locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392762:Quantitative [Quantitative Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in late onset Alzheimer's disease pedigrees."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030761:pedigrees [Intellectual Product]
   771   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.108: Science, 290, 2303-2304.[Abstract/Free FullText] Helisalmi, S., Hiltunen, M., Valonen, M., et al (1999) Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "290,"

Phrase: "2303-2304."

Phrase: "[Abstract/Free FullText"

Phrase: "] Helisalmi,"

Phrase: "S."

Phrase: ","

Phrase: "Hiltunen,"

Phrase: "M."

Phrase: ","

Phrase: "Valonen,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1999"

Phrase: ")"

Phrase: "Promoter polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(-491A/T) in the APOE gene"

Phrase: "of Finnish Alzheimer's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.109: Journal of Neurology, 246, 821-824.[CrossRef][Medline] Holmes, C., Arranz, M. 

Phrase: "Journal of Neurology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "246,"

Phrase: "821-824."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holmes,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Arranz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.110: J., Powell, J. 

Phrase: "J.,"

Phrase: "Powell,"

Phrase: "J."
Processing 00000000.tx.111: F., et al (1998) 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "5-HT2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415809:5-HT2A [Gene or Genome]
  1000   C1708300:5-HT2A [Gene or Genome]
   861   C1424232:HT2A [Gene or Genome]

Phrase: "and"

Phrase: "5-HT2C receptor polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]
   756   C0528200:5-HT2C Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "psychopathology in late onset Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033927:Psychopathology [Biomedical Occupation or Discipline]
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.112: Human Molecular Genetics, 7, 1507-1509.[Abstract/Free FullText] Kehoe, P., Wavrant-DeVrieze, F., Crook, R., et al (1999) A full genome scan for late onset Alzheimer's disease. 

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "7,"

Phrase: "1507-1509."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wavrant-DeVrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "et al (1999"

Phrase: ")"

Phrase: "A full genome scan for late onset Alzheimer's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1517519:Genome Scan [Molecular Biology Research Technique]
   742   C0017428:Genome [Gene or Genome]
   742   C0034606:Scan [Diagnostic Procedure]
   742   C0441633:Scan [Diagnostic Procedure]
   742   C2338314:Genome [Conceptual Entity]
   742   C2826292:SCAN [Finding]
Processing 00000000.tx.113: Human Molecular Genetics, 8, 237-245.[Abstract/Free FullText] Lambert, J. 

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "8,"

Phrase: "237-245."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.114: C., Berr, C., Pasquier, F., et al (1998) Pronounced impact of Th1/E47 cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. 

Phrase: "C., Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Pronounced impact of Th1/E47 cs mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "compared with -491"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "AT mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on neural APOE gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1412481:APOE gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "risk of developing Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.115: Human Molecular Genetics, 7, 1511-1516.[Abstract/Free FullText] Meyer, M. 

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "7,"

Phrase: "1511-1516."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meyer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.116: R., Tschanz, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tschanz,"

Phrase: "J."
Processing 00000000.tx.117: T., Norton, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Norton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.118: C., et al (1998) APOE genotype predicts when  not whether  one is predisposed to develop Alzheimer disease. 

Phrase: "C., et al (1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "predicts"

Phrase: "when"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "whether"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "predisposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231203:Predisposed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.119: Nature Genetics, 19, 321-322.[CrossRef][Medline] Myers, A., Holmans, P., Marshall, H., et al (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. 

Phrase: "Nature Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "19,"

Phrase: "321-322."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myers,"

Phrase: "A.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Susceptibility locus for Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.120: Science, 290, 2304-2305.[Abstract/Free FullText] Pearlson, G. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "290,"

Phrase: "2304-2305."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pearlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.121: D., Ross, C. 

Phrase: "D."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."
Processing 00000000.tx.122: A., Lohr, W. 

Phrase: "A.,"

Phrase: "Lohr,"

Phrase: "W."
Processing 00000000.tx.123: D., et al (1990) Association between family history of affective disorder and the depressive syndrome of Alzheimer's disease. 

Phrase: "D."

Phrase: ","

Phrase: "et al (1990"

Phrase: ")"

Phrase: "Association between family history of affective disorder"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   738   C0544093:Association, familial [Finding]
   738   C3645562:Historical association [Intellectual Product]
   731   C3266729:Family history of affective disorder [Finding]

Phrase: "and"

Phrase: "the depressive syndrome of Alzheimer's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086133:Depressive Syndrome [Mental or Behavioral Dysfunction]
   783   C0002395:Alzheimer Syndrome [Disease or Syndrome]
   783   C1857276:THE SYNDROME [Disease or Syndrome]
   753   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.124: American Journal of Psychiatry, 147, 452-456.[Abstract] Pericak-Vance, M. 

Phrase: "American Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "147,"

Phrase: "452-456."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.125: A., Bass, M. 

Phrase: "A.,"

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.126: P., Yamaoka, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.127: H., et al (1997) Complete genomic screen in late-onset familial Alzheimer disease. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al (1997"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "genomic screen in late-onset familial Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0220908:screen [Health Care Activity]
   744   C1305399:screen [Functional Concept]
   744   C1705053:Screen [Medical Device]
   703   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
Processing 00000000.tx.128: Evidence for a new locus on chromosome 12. 

Phrase: "Evidence for a new locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.129: JAMA, 278, 1237-1241.[Abstract] Sweet, R. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "278,"

Phrase: "1237-1241."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sweet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0453447:sweet [Food]
  1000   C1154613:sweet [Organism Function]
  1000   C1537081:Sweet [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.130: A., Nimgaonkar, V. 

Phrase: "A.,"

Phrase: "Nimgaonkar,"

Phrase: "V."
Processing 00000000.tx.131: L., Kamboh, M. 

Phrase: "L., Kamboh,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.132: I., et al (1998) Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Dopamine receptor genetic variation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042333:Genetic Variation [Natural Phenomenon or Process]
   812   C0205419:Variation [Qualitative Concept]

Phrase: "psychosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]

Phrase: "and"

Phrase: "aggression in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001807:Aggression [Mental or Behavioral Dysfunction]
Processing 00000000.tx.133: Archives of Neurology, 55, 1335-1340.[Abstract/Free FullText] Tunstall, N., Owen, M. 

Phrase: "Archives of Neurology,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0003738:Archives [Manufactured Object]
   790   C0027855:Neurology [Biomedical Occupation or Discipline]
   790   C1554162:Archive [Idea or Concept]
   718 E C0205494:Neurologic [Qualitative Concept]
   718 E C2707261:Neurological [Clinical Attribute]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "1335-1340."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tunstall,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.134: J., Williams, J., et al (2000) Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease. 

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Familial influence on variation"

Phrase: "in age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "behavioural phenotype in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1321146:Behavioral phenotype [Behavior]
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.135: British Journal of Psychiatry, 176, 156-159.[Abstract/Free FullText] Wisniewski, T., Dowjat, W. 

Phrase: "British Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "176,"

Phrase: "156-159."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dowjat,"

Phrase: "W."
Processing 00000000.tx.136: K., Buxbaum, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.137: D., et al (1998) A novel Polish presenilin-2 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. 

Phrase: "D."

Phrase: ","

Phrase: "et al (1998"

Phrase: ")"

Phrase: "A novel Polish presenilin-2 mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(P117L"

Phrase: ")"

Phrase: "is"

Phrase: "associated with familial Alzheimer's disease"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0243083:associated disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "leads to death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0011065:Death [Organism Function]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1306577:Death, NOS [Finding]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "as the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 28 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.138: Neuroreport, 9, 217-221.[Medline] Wu, W. 

Phrase: "Neuroreport,"

Phrase: "9,"

Phrase: "217-221."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W."
Processing 00000000.tx.139: S., Holmans, P., Wavrant-DeVrieze, F., et al (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. 

Phrase: "S."

Phrase: ","

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wavrant-DeVrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Genetic studies on chromosome 12"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1273411:Chromosome studies [Laboratory Procedure]
   790   C2827447:Genetic Study [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.140: JAMA, 280, 619-622.[Abstract/Free FullText] Zurutuza, L., Verpillat, P., Raux, G., et al (2000) APOE promoter polymorphisms do not confer independent risk for Alzheimer's Disease in a French population. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "280,"

Phrase: "619-622."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zurutuza,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Verpillat,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Raux,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "et al (2000"

Phrase: ")"

Phrase: "APOE promoter polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confer"

Phrase: "independent risk for Alzheimer's Disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in a French population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.141: European Journal of Human Genetics, 8, 713-716.[CrossRef][Medline] Received for publication May 16, 2000. 

Phrase: "European Journal of Human Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "8,"

Phrase: "713-716."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Received for publication May 16,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2000."
Processing 00000000.tx.142: Revision received May 14, 2001. 

Phrase: "Revision"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439617:Revision [Temporal Concept]
  1000   C0558347:Revision [Therapeutic or Preventive Procedure]
  1000   C1527075:Revision [Therapeutic or Preventive Procedure]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 14,"

Phrase: "2001."
Processing 00000000.tx.143: Accepted for publication May 23, 2001. 

Phrase: "Accepted for publication May 23,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0450348:23 [Quantitative Concept]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.144: Related articles in BJP: Highlights of this issue ELIZABETH WALSH BJP 2002 180: 0. 

Phrase: "Related articles in BJP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "Highlights of this issue ELIZABETH WALSH BJP 2002 180"

Phrase: ":"

Phrase: "0."
Processing 00000000.tx.145: [Full Text]  Old age psychiatry ALISTAIR BURNS and IAN G. 

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]  Old age psychiatry ALISTAIR BURNS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0006434:Burns [Injury or Poisoning]
   771 E C1550619:Burn [Substance]
   717   C1273857:Old age psychiatry [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "IAN G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.146: McKEITH BJP 2002 180: 97-98. 

Phrase: "McKEITH BJP 2002 180"

Phrase: ":"

Phrase: "97-98."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.147: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

